Approach to congenital infections: Clinical sciences

Last updated: January 30, 2025

Approach to congenital infections: Clinical sciences

Pregnancy, childbirth, and the puerperium

Pregnancy, childbirth, and the puerperium

Preconception care: Clinical sciences
Antepartum fetal surveillance: Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Maternal D alloimmunization (prevention): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Fetal growth restriction: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Maternal D alloimmunization (management): Clinical sciences
Multifetal gestation: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Induction of labor: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Intrapartum fetal heart rate monitoring: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Pain management during labor: Clinical sciences
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Shoulder dystocia: Clinical sciences
Vaginal birth after cesarean (VBAC): Clinical sciences
Approach to postpartum fever: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Uterine atony: Clinical sciences
Immediate care of the well newborn: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to birth injury (pediatrics): Clinical sciences
Approach to complications of prematurity (early): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to congenital infections: Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Asthma in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Anatomy clinical correlates: Female pelvis and perineum
Chlamydia trachomatis
Neisseria gonorrhoeae
Streptococcus agalactiae (Group B Strep)
Treponema pallidum (Syphilis)
Toxoplasma gondii (Toxoplasmosis)
Cytomegalovirus
Hepatitis B and Hepatitis D virus
Herpes simplex virus
HIV (AIDS)
Influenza virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Congenital TORCH infections: Pathology review
Complications during pregnancy: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants

Decision-Making Tree

Transcript

Watch video only

Congenital infections occur when a bacterial, viral, or parasitic pathogen crosses the placenta during pregnancy or is acquired by the newborn during labor and delivery.

While some congenital infections are asymptomatic, many are associated with significant sequelae such as intrauterine growth restriction, microcephaly, hearing loss, and ocular abnormalities.

Traditionally, congenital infections have been grouped under the mnemonic TORCH, which stands for Toxoplasma, Other, Rubella, Cytomegalovirus, and Herpes simplex virus. The category Other continues to evolve and includes pathogens such as Zika virus, Varicella-zoster virus, syphilis, and human immunodeficiency virus.

When a patient presents with a chief concern suggesting a congenital infection, your first step is to obtain a focused history and physical examination.

This includes measurement of weight, length, and head circumference; as well as a fundoscopic exam and a hearing screen.

The antenatal history may reveal signs or symptoms of a maternal infection during the pregnancy; immunosuppression, or there might be no prenatal care.

The neonatal history may reveal that the infant was small for gestational age at birth; and the physical exam findings could include jaundice, hepatosplenomegaly or hsm, rash, or congenital malformations, depending on the type of infection.

With these findings, consider the possibility of a congenital infection.

Now here’s a clinical pearl to keep in mind! Various congenital infections present with jaundice, hepatosplenomegaly, and rash, so consider ordering a CBC and CMP during your initial workup. The CBC commonly demonstrates anemia and thrombocytopenia, while the CMP may demonstrate elevated serum bilirubin levels. Remember, these findings aren’t specific, so correlate the results with clinical findings to focus your diagnostic evaluation!

Once you’ve considered a congenital infection, begin your evaluation by assessing for a heart murmur.

If you detect a murmur, consider congenital rubella.

In this case, a review of the maternal history often reveals a mild febrile illness or rash early in pregnancy.

The newborn exam will demonstrate a bluish-purple maculopapular rash, called a blueberry muffin rash, which is due to dermal hematopoiesis. A systolic or continuous machinery-like heart murmur that radiates from the left upper sternal border to the back will also be present. The eye examination may reveal cataracts, glaucoma, or salt-and-pepper retinopathy, while a hearing screen commonly demonstrates sensorineural hearing loss or SNHL.

Next, obtain a rubella IgM titer and viral cultures of the blood, urine, cerebrospinal fluid, and oral or nasal secretions. Additionally, consider obtaining IgG titers, and don’t forget to order an echocardiogram.

If the IgM titer or the cultures are positive or if IgG titers are rising, and the echocardiogram reveals patent ductus arteriosus or peripheral pulmonary stenosis, diagnose congenital rubella.

Here’s a clinical pearl to keep in mind! Congenital rubella is rare in developed countries due to widespread vaccination, but if an unvaccinated patient becomes infected during pregnancy, gestational age impacts disease severity. Infection before 4 weeks of gestation can cause pregnancy loss, while infection between 4 weeks and 4 months often causes congenital defects. However, infection after 4 months usually doesn’t cause sequelae.

Now let’s go back and take a look at newborns and infants with no heart murmur!

Your next step is to assess head circumference.

If you identify microcephaly, your next step is to look for skin rash.

If a skin rash is present, assess for maternal exposure to cats or cat feces.

When there’s a combination of microcephaly and a rash, but no exposure to cats, consider cytomegalovirus, or CMV infection.

There might be a maternal report of a mild flu-like illness during pregnancy; and the neonatal history often reveals that the infant was premature or small for gestational age. The newborn is usually asymptomatic at birth, though they may develop seizures and developmental delay later.

The newborn exam typically demonstrates a blueberry muffin rash; while fundoscopy findings include chorioretinitis and retinal hemorrhage; and the hearing screen reveals sensorineural hearing loss.

To confirm the diagnosis, order a urine or salivary polymerase chain reaction, or PCR, and consider a viral culture of the blood or cerebrospinal fluid. Finally, obtain an MRI of the brain.

Positive PCR testing or cultures, with imaging findings of periventricular cysts or calcifications, and ventriculomegaly, confirm the diagnosis of congenital CMV infection.

Here’s a high-yield fact! Since most reproductive-aged patients are seropositive for CMV, prenatal screening isn’t routinely performed. During pregnancy, primary infection poses the highest risk to the fetus, but reactivation of latent maternal infection can also cause congenital CMV.

Alright, now let’s discuss patients with microcephaly, a rash, and an exposure to cats or cat feces.

In this case, consider a Toxoplasma gondii infection.

In addition to exposure to cats, the maternal history may include an exposure to raw meat or milk, or contaminated soil or water. The newborn is likely to be asymptomatic at birth but may develop seizures.

The physical exam commonly reveals a blueberry muffin rash, hypotonia, and microphthalmia; and the eye exam typically demonstrates chorioretinitis.

To confirm the diagnosis, order a Toxoplasma IgA, IgG, and IgM titer; a PCR of the placenta, blood, or CSF; and an MRI of the brain.

If the titers and PCR are positive and the imaging demonstrates cortical intracranial calcifications, hydrocephalus, and ventriculomegaly, diagnose congenital toxoplasmosis, caused by the parasite Toxoplasma gondii.

Next, let’s discuss patients who have microcephaly but no skin rash.

In this case, consider a Zika virus infection. The maternal history may include travel or residence in an endemic region, or a mild viral illness during pregnancy.

The newborn exam may demonstrate severe microcephaly, hypertonia, and possibly contractures such as clubfoot; while the fundoscopic exam might reveal macular scarring and chorioretinal atrophy.

To confirm the diagnosis, obtain nucleic acid amplification, or NAAT testing for Zika virus as well as IgM titers and an MRI of the brain or head ultrasound.

If the NAAT and IgM titers are positive, and imaging demonstrates cerebellar hypoplasia, ventriculomegaly, or lissencephaly, diagnose congenital Zika infection.

Sources

  1. " Concerning Newborn Rashes and Developmental Abnormalities: Part II: Congenital Infections, Ichthyosis, Neurocutaneous Disorders, Vascular Malformations, and Midline Lesions. " Pediatr Rev. (2023 Aug 1;44(8):447-465. )
  2. "Focus on diagnosis: congenital infections (TORCH) [published correction appears in Pediatr Rev. 2012 Mar;33(3):109]." Pediatr Rev (2011;32(12):537-542. )
  3. "Nelson Essentials of Pediatrics. 8th ed. " Elsevier (2023.)
  4. "American Academy of Pediatrics Textbook of Pediatric Care. 2nd ed. " American Academy of Pediatrics (2017)
  5. "The Term Newborn: Congenital Infections. " Clin Perinatol (2021;48(3):485-511. )
  6. "Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy." Obstet Gynecol (2015 Jun;125(6):1510-152)